As of September 2023 VectivBio has a market cap of $1.05 Billion. This makes VectivBio the world's 4835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $1.05 B | 94.69% |
2022 | $0.54 B | 208.71% |
2021 | $0.17 B |
On Sep 29th, 2023 the market cap of VectivBio was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $10.89 M | -98.97% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.17 B | -83.40% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $0.73 B | -30.97% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $1.72 B | 62.70% | Jersey |